MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Genetics"

  • 2022 International Congress

    Dopa-responsive Combined Dystonia Due to ATP1A3 Gene Variant

    M. Soares, J. Parmera, M. Bezerra (São Paulo, Brazil)

    Objective: To describe a remarkable case of a patient with an atypical ATP1A3 phenotype with levodopa responsiveness, expanding our understanding of this gene mutation. Background: The ATP1A3-spectrum disorders…
  • 2022 International Congress

    X-Linked Dystonia Parkinsonism as the cause of Isolated Lingual Dystonia (ILD)

    D. Dakay, G. Saranza, Z. Leonardo, C. Klein, N. Brüggemann, A. Westenberger (Mandaue City, Philippines)

    Objective: This report aims to describe a 43-year-old Filipino male with ILD aggravated by speech and swallowing. This paper highlights the importance of including XDP…
  • 2022 International Congress

    DHDDS and NUS1: A converging pathway and common phenotype

    L. Williams, J. Qiu, S. Waller, N. Elserafy, M. Tchan, P. Procopis, H. Sampaio, S. Mohammad, H. Morales-Briceño, V. Fung (Sydney, Australia)

    Objective: To report on the clinical spectrum of variants affecting dehydrodolichol diphosphate synthetase (DHDDS) and nuclear undecaprenyl pyrophosphate Synthase 1 (NUS1) and particularly to highlight their…
  • 2022 International Congress

    Highlighting the dystonic phenotype related to GNAO1

    T. Wirth, G. Garone, M. Kurian, A. Piton, F. Milan, A. Telegrafi, N. Drouot, G. Rudolf, J. Chelly, W. Marks, L. Burglen, D. Demailly, P. Coubes, M. Castro-Jimenez, S. Joriot, J. Ghoumid, J. Belin, J-M. Faucheux, L. Blumkin, M. Hull, M. Parnes, C. Ravelli, A. Nemeth, M. Smith, A. Barnicoat, C. Ewenczyk, A. Méneret, E. Roze, B. Keren, C. Mignot, C. Beroud, F. Acosta, C. Nowak, W. Wilson, D. Steel, A. Capuano, M. Vidailhet, J-P. Lin, C. Tranchant, L. Cif, D. Doummar, M. Anheim (Strasbourg, France)

    Objective: To characterize the clinical and genetic features of patients with mild GNAO1-related phenotype with prominent movement disorders. Background: Most reported patients carrying GNAO1 mutations…
  • 2022 International Congress

    A novel compound heterozygous PANK2 gene mutation in a South- Asian sexagenarian with atypical PKAN

    K. Pillai, B. Maramattom, S. Grover, A. Kishore (Kochi, India)

    Objective: To study the clinical course, imaging and genetics of a case of late-onset dystonia-parkinsonism suspected to have Neurodegeneration with Brain Iron Accumulation (NBIA). Background:…
  • MDS Virtual Congress 2021

    Whole genome sequencing aids in diagnosing GCH1 dopa responsive dystonia in two Peruvian patients and influences medical management

    L. Urbina-Ramirez, J. La Serna-Infantes, E. Sarapura-Castro, A. Rivera-Valdivia, E. Thorpe, D. Perry, K. Milla-Neyra, C. Galarreta, M. Dueñas-Roque, M. Cornejo-Olivas (Lima, Peru)

    Objective: To describe the clinical features and treatment response of two Peruvian patients with GHC1 dopa responsive dystonia diagnosed by whole genome sequencing. Background: Pathogenic variants in…
  • MDS Virtual Congress 2021

    Diagnosis and management of Myoclonus Dystonia Syndrome: a Survey of the European Reference Network for Rare Neurological Diseases.

    M. Vanegas, E. Timmers, F. Hamami, S. Boesch, W. Vandenberghe, O. Burgazlieva, M. Møller, L. Hjermind, M. Vidailhet, A. Meneret, T. Bäumer, S. Siegert, T. Gasser, L. Schoels, J. Molnar, A. Capuano, F. Nicita, G. Zorzi, A. Albanese, A. Federico, E. Lohmann, J. Guk, M. Willemsen, N. Wolf, M. Dec-Cwiek, D. Neubauer, D. Flisar, V. Gonzalez, A. Darling, M. Marti, H. Houlden, C. Reinhard, A. Weissbach, M. Tijssen, B. Perez-Dueñas (Barcelona, Spain)

    Objective: To evaluate the diagnostic and treatment strategies in Myoclonus Dystonia Syndrome (MDS) used by experts from the European Reference Network for rare neurological diseases…
  • MDS Virtual Congress 2021

    MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR

    A. Weissbach, R. Herzog, M. Pauly, L. Hahn, I. König, S. Camargos, B. Jeon, M. Kurian, T. Opladen, N. Brüggemann, C. Klein, K. Lohmann (Lübeck, Germany)

    Objective: To systematically review information regarding genotype, phenotype, and biochemistry in dopa-responsive dystonia (DRD). Background: To date, five causative genes (GCH1, TH, SPR, PTS, and…
  • MDS Virtual Congress 2021

    A Child with Fever-Induced Paroxysmal Weakness and Encephalopathy with ATP1A3 mutation

    D. Ferman, Q. Luc (Los Angeles, USA)

    Objective: We describe a case of fever-induced paroxysmal weakness and encephalopathy (FIPWE), also known as relapsing encephalopathy with cerebellar ataxia (RECA) and expand the phenotypic…
  • MDS Virtual Congress 2021

    Whole-Exome Sequencing in a Movement Disorders Clinic

    C. Shah, L. Robak, E. Hill, J. Jankovic (Houston, USA)

    Objective: To evaluate the diagnostic utility of whole-exome sequencing (WES) in select patients with a movement disorder. Background: Many patients with suspected genetic movement disorders…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley